Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →
Sandoz and Henlius Enter Strategic Partnership to Develop Up to 10 Biosimilars.
Aug 17, 2026•about 2 hours ago
Contract Type
partnership
Description
Sandoz has announced a major collaboration agreement with Shanghai Henlius Biotech, Inc. to develop and commercialize up to 10 biosimilars. This partnership will bolster Sandoz's portfolio and expand patient access to essential biosimilar therapies globally.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months